Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(10):1300–1307. doi: 10.1038/bjc.1997.552

Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage.

R N Turner 1, G W Aherne 1, N J Curtin 1
PMCID: PMC2228144  PMID: 9374375

Abstract

The novel antifolate lometrexol (5,10-dideazatetrahydrofolate) inhibits de novo purine biosynthesis, and co-incubation with hypoxanthine abolishes its cytotoxicity. The prevention of hypoxanthine rescue from an antipurine antifolate by the nucleoside transport inhibitor dipyridamole was investigated for the first time in nine human and rodent cell lines from seven different tissues of origin. In A549, HeLa and CHO cells, dipyridamole prevented hypoxanthine rescue and so growth was inhibited by the combination of lometrexol, dipyridamole and hypoxanthine, but in HT29, HCT116, KK47, MDA231, CCRF CEM and L1210 cells dipyridamole had no effect and the combination did not inhibit growth. Dipyridamole inhibited hypoxanthine uptake in A549 but not in CCRF CEM cells. Dipyridamole prevented the hypoxanthine-induced repletion of dGTP pools, depleted by lometrexol, in A549 but not in CCRF CEM cells. Thus, the selective growth-inhibitory effect of the combination of lometrexol, dipyridamole and hypoxanthine is apparently due to the dipyridamole sensitivity (ds) or insensitivity (di) of hypoxanthine transport. Both the human and murine leukaemic cells are of the di phenotype. If this reflects the transport phenotype of normal bone marrow it would suggest that the combination of lometrexol, dipyridamole and hypoxanthine might be selectively toxic to certain tumour types and have reduced toxicity to the bone marrow.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beardsley G. P., Moroson B. A., Taylor E. C., Moran R. G. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem. 1989 Jan 5;264(1):328–333. [PubMed] [Google Scholar]
  2. Belt J. A. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Mol Pharmacol. 1983 Nov;24(3):479–484. [PubMed] [Google Scholar]
  3. Belt J. A., Marina N. M., Phelps D. A., Crawford C. R. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul. 1993;33:235–252. doi: 10.1016/0065-2571(93)90021-5. [DOI] [PubMed] [Google Scholar]
  4. Benz C., Cadman E. Biochemical alterations during unperturbed suspension growth of L1210 cells. Cancer Res. 1981 Jan;41(1):157–163. [PubMed] [Google Scholar]
  5. Bökkerink J. P., De Abreu R. A., Bakker M. A., Hulscher T. W., Van Baal J. M., De Vaan G. A. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts. Biochem Pharmacol. 1986 Oct 15;35(20):3557–3564. doi: 10.1016/0006-2952(86)90626-x. [DOI] [PubMed] [Google Scholar]
  6. Chan T. C., Howell S. B. Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity. Eur J Cancer. 1990;26(8):907–911. doi: 10.1016/0277-5379(90)90198-3. [DOI] [PubMed] [Google Scholar]
  7. Cohen J. D., Robins H. I., Katz T. B., Miller E. M., Kuzminsky S. R., Javid M. J. Deoxyribonucleoside triphosphate pools and thymidine chemosensitization in human T-cell leukemia. Leuk Res. 1993 Feb;17(2):167–174. doi: 10.1016/0145-2126(93)90062-p. [DOI] [PubMed] [Google Scholar]
  8. Curtin N. J., Harris A. L., Aherne G. W. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res. 1991 May 1;51(9):2346–2352. [PubMed] [Google Scholar]
  9. Domin B. A., Mahony W. B., Zimmerman T. P. Purine nucleobase transport in human erythrocytes. Reinvestigation with a novel "inhibitor-stop" assay. J Biol Chem. 1988 Jul 5;263(19):9276–9284. [PubMed] [Google Scholar]
  10. Erba E., Sen S., Sessa C., Vikhanskaya F. L., D'Incalci M. Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid. Br J Cancer. 1994 Feb;69(2):205–211. doi: 10.1038/bjc.1994.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fox M., Boyle J. M., Kinsella A. R. Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer. 1991 Sep;64(3):428–436. doi: 10.1038/bjc.1991.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garrett C., Santi D. V. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 1979 Nov 1;99(2):268–273. doi: 10.1016/s0003-2697(79)80005-6. [DOI] [PubMed] [Google Scholar]
  13. Goel R., Howell S. B. Modulation of the activity of cancer chemotherapeutic agents by dipyridamole. Cancer Treat Res. 1991;58:19-44, 155-6. doi: 10.1007/978-1-4615-3876-9_2. [DOI] [PubMed] [Google Scholar]
  14. Griffith D. A., Jarvis S. M. High affinity sodium-dependent nucleobase transport in cultured renal epithelial cells (LLC-PK1). J Biol Chem. 1993 Sep 25;268(27):20085–20090. [PubMed] [Google Scholar]
  15. Halloran M. J., Parker C. W. The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. J Immunol. 1966 Mar;96(3):373–378. [PubMed] [Google Scholar]
  16. Kinsella A. R., Haran M. S. Decreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts. Cancer Res. 1991 Apr 1;51(7):1855–1859. [PubMed] [Google Scholar]
  17. Kraupp M., Marz R. Membrane transport of nucleobases: interaction with inhibitors. Gen Pharmacol. 1995 Oct;26(6):1185–1190. doi: 10.1016/0306-3623(95)00005-l. [DOI] [PubMed] [Google Scholar]
  18. Kwok J. B., Tattersall M. H. Inhibition of 2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid cytotoxicity by 5,10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate pools. Biochem Pharmacol. 1991 Jul 15;42(3):507–513. doi: 10.1016/0006-2952(91)90312-s. [DOI] [PubMed] [Google Scholar]
  19. Marina N. M., Belt J. A. Effect of nucleoside transport inhibitors on thymidine salvage and the toxicity of nucleoside analogs in mouse bone marrow granulocyte-macrophage progenitor cells. Cancer Commun. 1991;3(12):367–372. doi: 10.3727/095535491820873722. [DOI] [PubMed] [Google Scholar]
  20. Mattano S. S., Palella T. D., Mitchell B. S. Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools. Cancer Res. 1990 Aug 1;50(15):4566–4571. [PubMed] [Google Scholar]
  21. Piall E. M., Aherne G. W., Marks V. The quantitative determination of 2'-deoxycytidine-5'-triphosphate in cell extracts by radioimmunoassay. Anal Biochem. 1986 Apr;154(1):276–281. doi: 10.1016/0003-2697(86)90526-9. [DOI] [PubMed] [Google Scholar]
  22. Piall E. M., Curtin N. J., Aherne G. W., Harris A. L., Marks V. The quantitation by radioimmunoassay of 2'-deoxyuridine 5'-triphosphate in extracts of thymidylate synthase-inhibited cells. Anal Biochem. 1989 Mar;177(2):347–352. doi: 10.1016/0003-2697(89)90064-x. [DOI] [PubMed] [Google Scholar]
  23. Pizzorno G., Moroson B. A., Cashmore A. R., Beardsley G. P. (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells. Cancer Res. 1991 May 1;51(9):2291–2295. [PubMed] [Google Scholar]
  24. Plagemann P. G., Wohlhueter R. M. Hypoxanthine transport in mammalian cells: cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine. J Membr Biol. 1984;81(3):255–262. doi: 10.1007/BF01868718. [DOI] [PubMed] [Google Scholar]
  25. Plagemann P. G., Wohlhueter R. M. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim Biophys Acta. 1984 Jun 13;773(1):39–52. doi: 10.1016/0005-2736(84)90548-0. [DOI] [PubMed] [Google Scholar]
  26. Plagemann P. G., Wohlhueter R. M., Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta. 1988 Oct 11;947(3):405–443. doi: 10.1016/0304-4157(88)90002-0. [DOI] [PubMed] [Google Scholar]
  27. Ray M. S., Muggia F. M., Leichman C. G., Grunberg S. M., Nelson R. L., Dyke R. W., Moran R. G. Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J Natl Cancer Inst. 1993 Jul 21;85(14):1154–1159. doi: 10.1093/jnci/85.14.1154. [DOI] [PubMed] [Google Scholar]
  28. Ross D. D., Akman S. A., Schrecker A. W., Bachur N. R. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. Cancer Res. 1981 Nov;41(11 Pt 1):4493–4498. [PubMed] [Google Scholar]
  29. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 Jul 4;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107. [DOI] [PubMed] [Google Scholar]
  30. Slaughter R. S., Barnes E. M., Jr Hypoxanthine transport by Chinese hamster lung fibroblasts: Kinetics and inhibition of nucleosides. Arch Biochem Biophys. 1979 Oct 1;197(1):349–355. doi: 10.1016/0003-9861(79)90255-8. [DOI] [PubMed] [Google Scholar]
  31. Sokoloski J. A., Pizzorno G., Beardsley G. P., Sartorelli A. C. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF). Oncol Res. 1993;5(8):293–299. [PubMed] [Google Scholar]
  32. Spyrou G., Reichard P. Dynamics of the thymidine triphosphate pool during the cell cycle of synchronized 3T3 mouse fibroblasts. Mutat Res. 1988 Jul-Aug;200(1-2):37–43. doi: 10.1016/0027-5107(88)90069-3. [DOI] [PubMed] [Google Scholar]
  33. Tattersall M. H., Slowiaczek P., De Fazio A. Regional variation in human extracellular purine levels. J Lab Clin Med. 1983 Sep;102(3):411–420. [PubMed] [Google Scholar]
  34. Tyrsted G. The pool size of deoxyguanosine 5'-triphosphate and deoxycytidine 5'-triphosphate in phytohemagglutinin-stimulated and non-stimulated human lymphocytes. Exp Cell Res. 1975 Mar 15;91(2):429–440. doi: 10.1016/0014-4827(75)90124-x. [DOI] [PubMed] [Google Scholar]
  35. Van Mouwerik T. J., Pangallo C. A., Willson J. K., Fischer P. H. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. Biochem Pharmacol. 1987 Mar 15;36(6):809–814. doi: 10.1016/0006-2952(87)90168-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES